The NDUFB2 antibody targets the NDUFB2 protein, a subunit of Complex I (NADH dehydrogenase [ubiquinone] 1 beta subcomplex, 2) in the mitochondrial electron transport chain. This antibody is widely used in research to study mitochondrial function, oxidative phosphorylation, and diseases associated with Complex I dysfunction.
Gene Location: The NDUFB2 gene is located on chromosome 7q34, spanning 9,966 base pairs and comprising 4 exons .
Protein Characteristics: The encoded protein is a 12 kDa mitochondrial accessory subunit with a hydrophobic transmembrane domain and a hydrophilic domain interacting with Complex I’s peripheral arm .
Role in Complex I: NDUFB2 stabilizes the complex but does not directly participate in catalysis. It facilitates electron transfer from NADH to ubiquinone, a critical step in ATP synthesis .
The antibody is employed in:
Western Blot (WB): Detects a 12 kDa band in human, mouse, and rat tissues (e.g., skeletal muscle, brain) .
Immunohistochemistry (IHC): Localizes NDUFB2 in mitochondrial-rich tissues (e.g., heart, liver) .
Immunofluorescence (IF): Visualizes mitochondrial localization in cell lines like C2C12 .
| Application | Recommended Dilution | Reactivity |
|---|---|---|
| Western Blot | 1:500–1:1000 | Human, mouse, rat |
| Immunohistochemistry | 1:50–1:500 | Human, mouse |
| Immunofluorescence | 1:200–1:800 | Mouse |
Venous Thromboembolism (VTE): High NDUFB2 expression correlates with VTE in cirrhotic patients, suggesting its role in mitochondrial dysfunction and oxidative stress .
Cancer Prognosis: Elevated NDUFB2 levels are linked to poor survival in glioblastoma and gliomas .
Mitochondrial Disorders: Mutations in NDUFB2 are implicated in Complex I deficiency, a cause of neurodegenerative diseases .